Indegene cash flow

Latest FY26
Cash from operations
₹651cr+47.3% on FY25
Capital spending
₹44.3cr+47.7% on FY25
Free cash flow
₹607cr+47.2% on FY25
Cash from financing
−₹82.6cr₹288 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
Adjustments to reconcile profit — non-cash items
—12780.276.1
—15.919.447.1
—−17.1−50.1−29.6
—−19.20.00.0
—25.617.421.3
—5.41.7−6.4
—−9.90.0−13.8
—0.0−30.1−16.5
Changes in working capital
—3.5−82.031.2
—−23.134.3−30.1
—14461.174.2
—22.110.720.5
Cash from operating activities
540525539459
—27362.6174
—798602633
—148160125
—651442508
Cash from investing activities
—44.330.010.7
—0.0111172
—0.00.013.5
—12.648.626.1
—−481−590−157
—−512−683−327
Cash from financing activities
—5.37330.0
—0.04036.7
—39.90.027.9
—0.010.331.6
—48.00.00.0
—0.031.80.0
—−82.6288−66.2
—55.846.7114
—4.05.70.7
—59.852.4115
—301241189
Reference items
683619534505
16.5%17.6%18.8%19.5%
607607412497
——−1.5—
₹25.22₹25.22₹17.13₹20.67
22.53×———
—1.62×1.09×1.51×
—148160125
——10.331.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

INDGN₹568.05

Indegene Ltd.

· Pharma & Health
₹ CrorePeersSYNGENELTTSGRANULESJUBLPHARMAKIMSERISEMCUREONESOURCEMcap ₹13,662 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation76.180.2126.5—
+ Finance Costs47.119.415.9—
+ Interest Income-29.6-50.1-17.1—
+ Dividend Income0.00.0-19.2—
+ Share-based Payments21.317.425.6—
+ Unrealised FX (Gain) / Loss-6.41.75.4—
+ Other Non-cash Items-13.80.0-9.9—
+ Other Reconciling Items-16.5-30.10.0—
Changes in Working Capital
+ Trade Receivables — Current31.2-82.03.5—
+ Other Current Assets-30.134.3-23.1—
+ Other Current Liabilities74.261.1143.7—
+ Provisions — Current20.510.722.1—
Cash from Operating Activities
Profit Before Tax (per I/S)458.6539.3525.0539.9
+ Total Adjustments (incl. Working Capital)174.062.6273.4—
Cash from Operations (pre-tax)632.6601.9798.4—
+ Income Taxes Paid124.9160.0147.6—
Cash from Operating Activities507.7441.9650.8—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)10.730.044.3—
+ Purchase of Investments (Equity / Debt)172.1111.30.0—
+ Loans & Advances Made13.50.00.0—
+ Interest Received — Investing26.148.612.6—
+ Other Inflows / (Outflows) — Investing-157.0-590.0-480.7—
Cash from Investing Activities-327.2-682.7-512.4—
Cash from Financing Activities
+ Proceeds from Issue of Shares0.0732.75.3—
+ Repayment of Borrowings6.7403.10.0—
+ Payment of Lease Liabilities27.90.039.9—
+ Interest Paid31.610.30.0—
+ Dividends Paid0.00.048.0—
+ Income Taxes (Paid) / Refund — Financing0.031.80.0—
Cash from Financing Activities-66.2287.5-82.6—
Net Changes in Cash (pre-FX)114.346.755.8—
+ Effect of FX Rate Changes on Cash0.75.74.0—
Net Changes in Cash115.052.459.8—
Closing Cash188.6241.0300.8—
Reference Items
EBITDA505.4534.3619.0683.0
EBITDA Margin %19.5218.8217.6316.53
Free Cash Flow (CFO − Capex)497.0411.9606.5606.5
Free Cash Flow to Equity—-1.5——
Free Cash Flow per Basic Share20.6717.1325.2225.22
Price to Free Cash Flow———22.53
Cash Flow to Net Income1.511.091.62—
Cash Paid for Taxes124.9160.0147.6—
Cash Paid for Interest31.610.3——
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.